What Does BB/TM Mean?

The Literal Answer: What BB/TM Stands For

BB/TM stands for Blood Banking/Transfusion Medicine, and in the context of this site it refers specifically to the initial subspecialty certification offered by the American Board of Pathology (ABPath). It is not a generic industry term and it is not interchangeable with other credentials that happen to share the same three letters. When physicians say they hold "BB/TM certification," they mean they have passed ABPath's subspecialty examination in Blood Banking/Transfusion Medicine after completing board-eligible pathology training and a dedicated fellowship.

If you're just getting oriented, our companion piece on What Is BB/TM? covers the broader picture, while BB/TM Meaning and What Does BB/TM Stand For? dig into the terminology from slightly different angles. This article focuses on what the credential actually involves: who administers it, how the exam is built, and what it takes to earn and keep it.

Who Grants BB/TM and Why It Matters

The American Board of Pathology is the sole certifying body for this credential. That matters because ABPath sets every operational detail: the eligibility pathway, the fee schedule, the testing windows, the blueprint, and the maintenance-of-certification rules. There is no alternate route to this particular BB/TM through a different organization - if a source describes different fees, different pass rates, or a different governing body, it is describing a different credential that happens to share the acronym.

For pathologists, ABPath subspecialty certification functions as a formal signal that a physician has completed focused fellowship training in transfusion medicine on top of general pathology certification. Hospitals, blood centers, and academic medical centers use it as a credentialing benchmark when hiring medical directors for transfusion services, apheresis units, and blood bank laboratories.

Inside the Exam: Format, Timing, and Question Style

The BB/TM exam is a one-day, computer-based test delivered at Pearson VUE Professional Testing Centers. It consists of 280 single-best-answer multiple-choice questions spread across six sections that blend written and practical material. "Practical" in this context doesn't mean a bench exercise - it means questions built around antibody-identification panels, images, charts, graphs, tables, diagrams, formulas, and calculations that mirror the kind of interpretive work a transfusion medicine physician does daily.

The 2026 schedule allots six hours and 22 minutes of actual testing time. The full scheduled day runs eight hours and 52 minutes once you account for the tutorial, a survey, lunch, and other scheduled breaks. That gap between testing time and total day length is worth internalizing when you plan your exam day - you are not sitting continuously for nearly nine hours, but you do need to pace yourself across a long day with interruptions.

For a full breakdown of what to expect question-by-question, see How Hard Is the BB/TM Exam? Complete Difficulty Guide 2026, and for exact scheduling logistics check BB/TM Exam Dates 2026: Testing Windows, Deadlines & Scheduling.

The 15 Domains BB/TM Actually Tests

ABPath's 2026 blueprint organizes content into 15 domains with published approximate Written/Practical weightings that total 100%. Understanding these weights is the single most useful thing you can do before building a study plan, because they tell you where the exam actually concentrates its questions.

The remaining domains, in the order they appear on the official blueprint, are: Histocompatibility and Tissue Banking (1%), RBCs and RBC Components (10%), Apheresis (8%), Hazards of Transfusion: Specific Adverse Events (10%), Plasma Components and Derivatives (6%), Infectious Hazards of Transfusion (4%), Blood Donors and Blood Collection (7%), Management, Quality, Legal, & Regulatory Issues in Transfusion Medicine & Transplantation (6%), Surgery Patients (7%), Biovigilance (1%), Platelet and Platelet Components (6%), Obstetric and Pediatric Patients (7%), and Management and Informatics-General (2%).

Notice that the four smallest domains - Histocompatibility and Tissue Banking, Biovigilance, Management and Informatics-General, and Infectious Hazards of Transfusion - together still account for a meaningful chunk of the exam even though each is individually small. Skipping them because they seem minor is a common mistake. For a domain-by-domain study breakdown, see BB/TM Exam Domains 2026: Complete Guide to All 15 Content Areas.

Who Can Sit for BB/TM: Eligibility Requirements

You cannot register for BB/TM as a standalone credential from scratch. ABPath requires candidates to already hold primary certification in AP/CP or CP, or primary certification from another ABMS member board. On top of that, candidates must complete 12 months of ACGME-accredited Blood Banking/Transfusion Medicine fellowship training. Certification itself further requires a qualifying medical degree, verification of the training program, and a full unrestricted medical license.

In practice, this means BB/TM is not a credential a medical laboratory scientist or generalist can pursue directly - it sits at the end of a pathology residency plus a dedicated fellowship year. If you're mapping out the pathway, BB/TM Requirements 2026: Eligibility, Prerequisites & How to Qualify walks through each prerequisite in sequence.

2026 Fees and Testing Windows

The 2026 examination fee is $2,100, which includes a $200 nonrefundable administrative fee. Testing occurs at Pearson VUE Professional Testing Centers during a defined window of September 8-28, 2026, rather than on a single fixed date - candidates schedule an appointment within that window.

Because the testing window spans roughly three weeks in September, scheduling early with Pearson VUE gives you more flexibility over which day and testing center you get. See BB/TM Exam Dates 2026: Testing Windows, Deadlines & Scheduling for the deadline sequence leading up to that window.

How Passing Actually Works

BB/TM uses a criterion-referenced passing scaled score of 500 - not a fixed raw percentage like "you need 70% correct." That distinction matters: the raw number of questions you need right can shift slightly between administrations depending on item difficulty, but the scaled standard stays anchored at 500. This is a standard approach in high-stakes medical certification and is explained in more depth in BB/TM Passing Score 2026: Exactly What You Need to Pass.

According to ABPath's 2025 Annual Report (released 2026), the overall pass rate for that cycle was 90% (44 of 49 candidates), with a first-time taker rate of 91% (39 of 43) and a repeat-taker rate of 83% (5 of 6). These figures reflect a single reporting cycle and should be read as a snapshot rather than a guaranteed outcome - for the full context of how these numbers are calculated and what they imply for preparation, see BB/TM Pass Rate 2026: What the Data Shows.

Keeping BB/TM Active After You Pass

BB/TM certificates carry no fixed expiration date, but staying certified is contingent on participating in ABPath's Continuing Certification program. The standard route requires 70 CME credits per two-year reporting cycle, with at least 80% of those credits related to your scope of practice. Diplomates must also complete at least two improvement-in-practice or quality-assurance activities per two-year cycle, alongside ongoing licensure and professionalism requirements.

Separately, ABPath's CertLink program assigns 10-15 questions quarterly. Diplomates must complete their assigned questions and maintain at least 60% correct cumulatively across the four-year assessment period. These maintenance obligations are entirely distinct from the initial certification exam's passing score - clearing the 280-question exam once does not exempt you from CertLink or CME requirements afterward.

BB/TM vs. SBB(ASCP): Don't Confuse Them

One of the most common mix-ups in this field is conflating ABPath's BB/TM physician certification with SBB(ASCP), the Specialist in Blood Banking credential offered by the American Society for Clinical Pathology's Board of Certification. They are different credentials for different roles: SBB(ASCP) is a laboratory specialist certification typically pursued by medical laboratory scientists and technologists, while BB/TM is a physician subspecialty certification requiring prior pathology board certification and fellowship training. If your career path involves a medical degree, residency, and fellowship, BB/TM is the relevant target; if it involves laboratory science training without a medical degree, SBB(ASCP) is the separate, non-overlapping route.

Who Pursues BB/TM and Why

Candidates for BB/TM are pathologists who have completed AP/CP or CP certification and then chosen to specialize further through a one-year ACGME-accredited fellowship in Blood Banking/Transfusion Medicine. After certification, these physicians typically move into roles such as medical director of a hospital transfusion service, blood center medical director, apheresis program director, or academic faculty overseeing transfusion medicine training. Employers in these settings - hospital systems, regional blood centers, and academic medical centers - generally list board certification or eligibility in BB/TM as a hiring expectation for director-level transfusion medicine positions. For a broader look at career paths and hiring patterns, see BB/TM Jobs, and for how the credential factors into long-term career value, Is the BB/TM Certification Worth It? Complete ROI Analysis 2026 and BB/TM Salary Guide 2026: Complete Earnings Analysis go into more detail.

If you're deciding whether to pursue fellowship training in the first place, BB/TM Training outlines what the fellowship year itself typically covers, and What Is BB/TM Certification? summarizes the credential from a pre-fellowship candidate's perspective.

Preparing Around the Blueprint, Not Around Generic Advice

Because the blueprint's weights are published and specific, the most efficient preparation strategy is to allocate study time roughly in proportion to domain weight rather than spreading effort evenly across all 15 areas. A candidate who spends equal time on Biovigilance (1%) and Clinical Practice (14%) is misallocating a scarce resource.

Within that structure, techniques like spaced repetition and timed practice blocks are useful specifically because the exam mixes recall-based written items with interpretive practical items - reviewing antibody panels a week after first encountering them, rather than only once, mirrors how the exam expects you to apply the material rather than just recognize it. A more detailed week-by-week plan, including how to sequence review sessions, is in BB/TM Study Guide 2026: How to Pass on Your First Attempt. If you want a condensed reference for last-minute review, BB/TM Cheat Sheet 2026: One-Page Review of Must-Know Facts compiles the highest-yield facts in one place.

To gauge your readiness against realistic question formats before test day, working through timed practice sets on the main BB/TM practice test platform can help you calibrate pacing across the exam's six hours and 22 minutes of testing time. Repeating that process on the practice site as you move through each domain block above lets you track which of the 15 areas still need attention before you finalize your Pearson VUE appointment within the September 8-28, 2026 window.

FAQ